Results 1 to 10 of about 117,049 (245)
Successful treatment of a patient with cutaneous co-infection caused by Mucor irregularis and Klebsiella pneumoniae, [PDF]
Anais Brasileiros de Dermatologia, 2020 The authors report a rare case of primary cutaneous mucormycosis caused by Mucor irregularis and cutaneous Klebsiella pneumoniae infections in a 67-year-old Chinese woman.
Siping Zhang, Kunju Zhu, Chi Zhang
doaj +1 more source
Pretreatmet with 5% lidocaine patch reduces cannula-induced and propofol-induced pain: a randomized, double-blind, placebo-controlled study [PDF]
Korean Journal of Anesthesiology, 2016 BackgroundThe purpose of this study was to determine the efficacy of 5% lidocaine patch in reducing propofol-induced pain and cannula-induced pain.MethodsIn a randomized, double-blind study, 126 patients were divided into one of three groups ...
Jung-Min Hong +7 more
doaj +1 more source
Characteristics and application of cutaneous spray preparations in dermal and transdermal drug delivery [PDF]
Arhiv za farmaciju, 2017 Liquid spray preparations for cutaneous administration are solutions, suspensions or emulsions that use compressed or converted gas to a liquid state, to disperse the active substance in the form of aerosols or they are propellant-free (not pressurized ...
Đekić Ljiljana +2 more
doaj +1 more source
Stem Cell Research & Therapy, 2021 Background Cutaneous wound healing and regeneration have become a recognized health challenge in the world, which causes severe damage to the mental and physical health of patients.
Yang Zhou +11 more
doaj +1 more source
Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
Dermatology and Therapy, 2023 As an immune-response modifier, imiquimod can bind to Toll-like receptors on immune cells and enhance innate and adaptive immune responses, exerting potential antitumor and antiviral effects, which led to its approval by the US Food and Drug ...
Xiaoyan Zhang, Yao Xie, Lin Wang
doaj +1 more source
Frontiers in Immunology, 2022 Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogleins. Rituximab effectively treats pemphigus by inducing remission and rapidly reducing corticosteroid dosage.
Ahreum Song +8 more
doaj +1 more source
Tropical Medicine and Infectious Disease, 2022 The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administration of pentavalent antimonials that are toxic and poorly tolerated.
Ernesto Rojas Cabrera +9 more
doaj +1 more source
Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review
Drugs in R&D, 2020 The prevalence of cutaneous adverse events attributable to newly approved anti-cancer drugs has been well reviewed in the dermatologic literature. In contrast, over 75% of US Food and Drug Administration approvals in the past 5 years have been for non ...
Paul C. Macklis +5 more
doaj +1 more source
Frontiers in Oncology, 2018 Antibodies against programmed cell death protein 1, such as nivolumab and pembrolizumab, are widely used for treating various cancers, including advanced melanoma.
Taku Fujimura +21 more
doaj +1 more source
Journal of International Medical Research, 2021 Sarcoidosis is a systemic granulomatous disease of unknown etiology that most frequently occurs in the lungs. However, cutaneous lesions are often the primary sign.
Wenxin Dong +3 more
doaj +1 more source